These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 11062061)
1. Effect of alpha-1 antitrypsin Portland variant (alpha 1-PDX) on HIV-1 replication. Bahbouhi B; Bendjennat M; Guétard D; Seidah NG; Bahraoui E Biochem J; 2000 Nov; 352 Pt 1(Pt 1):91-8. PubMed ID: 11062061 [TBL] [Abstract][Full Text] [Related]
2. Replication of HIV-1 viruses in the presence of the Portland alpha1-antitrypsin variant (alpha1-PDX) inhibitor. Bahbouhi B; Seidah NG; Bahraoui E Biochem J; 2001 Nov; 360(Pt 1):127-34. PubMed ID: 11695999 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of HIV-2(ROD) replication in a lymphoblastoid cell line by the alpha1-antitrypsin Portland variant (alpha1-PDX) and the decRVKRcmk peptide: comparison with HIV-1(LAI). Bahbouhi B; Bendjennat M; Chiva C; Kogan M; Albericio F; Giralt E; Seidah NG; Bahraoui E Microbes Infect; 2001 Nov; 3(13):1073-84. PubMed ID: 11709287 [TBL] [Abstract][Full Text] [Related]
4. Chemically induced CD4 mutants of a human T cell line. Evidence for dissociation between binding of HIV I envelope and susceptibility to HIV I infection and syncytia formation. Hillman K; Shapira-Nahor O; Gruber MF; Hooley J; Manischewitz J; Seeman R; Vujcic L; Geyer SJ; Golding H J Immunol; 1990 Mar; 144(6):2131-9. PubMed ID: 1690235 [TBL] [Abstract][Full Text] [Related]
5. Cells transfected with a non-neutralizing antibody gene are resistant to HIV infection: targeting the endoplasmic reticulum and trans-Golgi network. Zhou P; Goldstein S; Devadas K; Tewari D; Notkins AL J Immunol; 1998 Feb; 160(3):1489-96. PubMed ID: 9570571 [TBL] [Abstract][Full Text] [Related]
6. Effects of L- and D-REKR amino acid-containing peptides on HIV and SIV envelope glycoprotein precursor maturation and HIV and SIV replication. Bahbouhi B; Chazal N; Seidah NG; Chiva C; Kogan M; Albericio F; Giralt E; Bahraoui E Biochem J; 2002 Sep; 366(Pt 3):863-72. PubMed ID: 12071862 [TBL] [Abstract][Full Text] [Related]
7. HIV-1 proprotein processing as a target for gene therapy. Cordelier P; Zern MA; Strayer DS Gene Ther; 2003 Mar; 10(6):467-77. PubMed ID: 12621451 [TBL] [Abstract][Full Text] [Related]
8. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism. Blanco J; Barretina J; Clotet B; Esté JA J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site. Han W; Wind-Rotolo M; Kirkman RL; Morrow CD Virology; 2004 Dec; 330(1):221-32. PubMed ID: 15527848 [TBL] [Abstract][Full Text] [Related]
10. The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding. Li Y; Luo L; Thomas DY; Kang CY Virology; 2000 Jul; 272(2):417-28. PubMed ID: 10873786 [TBL] [Abstract][Full Text] [Related]
11. [HIV-1 env glycoprotein gp120 and gp160 expressed in vaccinia virus system and their antigenicity analysis]. Chen Y; Garcia R; Baralle FE Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Apr; 19(2):120-6. PubMed ID: 10453506 [TBL] [Abstract][Full Text] [Related]
12. Reverse transcriptase (RT)-independent as well as RT-dependent HIV-1 replication exists in syncytia following cell fusion. Takami Y; Ito M; Baba M; Ikuta K; Tanabe F; Shigeta S Fukushima J Med Sci; 1999 Jun; 45(1):13-24. PubMed ID: 10748552 [TBL] [Abstract][Full Text] [Related]
13. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex. Welman M; Lemay G; Cohen EA Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629 [TBL] [Abstract][Full Text] [Related]
14. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association. Maerz AL; Drummer HE; Wilson KA; Poumbourios P J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331 [TBL] [Abstract][Full Text] [Related]
15. Inhibiting lentiviral replication by HEXIM1, a cellular negative regulator of the CDK9/cyclin T complex. Shimizu S; Urano E; Futahashi Y; Miyauchi K; Isogai M; Matsuda Z; Nohtomi K; Onogi T; Takebe Y; Yamamoto N; Komano J AIDS; 2007 Mar; 21(5):575-82. PubMed ID: 17314519 [TBL] [Abstract][Full Text] [Related]
16. A mechanism of restricted human immunodeficiency virus type 1 expression in human glial cells. Shahabuddin M; Bentsman G; Volsky B; Rodriguez I; Volsky DJ J Virol; 1996 Nov; 70(11):7992-8002. PubMed ID: 8892923 [TBL] [Abstract][Full Text] [Related]
17. Expression and processing of the human immunodeficiency virus type 1 envelope glycoprotein. Chen SS Intervirology; 1996; 39(4):242-8. PubMed ID: 9078465 [TBL] [Abstract][Full Text] [Related]
18. Study of viral replication in HIV-1-infected CEM T-cell subclones which are reduced in their ability to form syncytia. Gruber MF; Hewlett IK; Simms T; Vujcic L; Manischewitz J; Golding H AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1139-46. PubMed ID: 1380260 [TBL] [Abstract][Full Text] [Related]
19. HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles. Legoff J; Bouhlal H; Lecerf M; Klein C; Hocini H; Si-Mohamed A; Muggeridge M; Bélec L Virol J; 2007 Jan; 4():2. PubMed ID: 17207276 [TBL] [Abstract][Full Text] [Related]
20. Origin-independent plasmid replication occurs in vaccinia virus cytoplasmic factories and requires all five known poxvirus replication factors. De Silva FS; Moss B Virol J; 2005 Mar; 2():23. PubMed ID: 15784143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]